Joan Miller (ophthalmologist)
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders (particularly diseases of the retina). She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
Joan Miller | |
---|---|
Born | Toronto, Ontario, Canada |
Alma mater | MIT (SB Biology) Harvard Medical School (MD) |
Known for | Development of Visudyne (verteporfin photodynamic therapy) Scientific basis of anti-VEGF therapy for eye disease |
Awards | Champalimaud Vision Award (2014) Mildred Weisenfeld Award (2015) |
Scientific career | |
Fields | Ophthalmology (vitreo-retinal surgery) Angiogenesis Neuroscience Genetics |
Institutions | Harvard Medical School Massachusetts Eye and Ear Massachusetts General Hospital |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.